A. Stebbins

发表

Atrial Fibrillation in the Setting of Acute Myocardial Infarction: The GUSTO-I Experience fn1

R. Califf, E. Topol, C. Granger, 1997 .

Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience.

R. Califf, E. Topol, L. Newby, 2002, Annals of emergency medicine.

Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial

Claes Held, Diego Ardissino, Karen Chiswell, 2017, European heart journal.

Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes.

Sunil V. Rao, V. Hasselblad, L. Newby, 2003, The American journal of cardiology.

Incidence and Outcomes Associated With Early Heart Failure Pharmacotherapy in Patients With Ongoing Cardiogenic Shock

E. Ohman, H. Dauerman, J. Parrillo, 2014, Critical care medicine.

Response to Exercise Training and Outcomes in Patients With Heart Failure and Diabetes Mellitus: Insights From the HF-ACTION Trial.

W. Kraus, S. Keteyian, I. Piña, 2016, Journal of cardiac failure.

Nesiritide, Renal Function, and Associated Outcomes During Hospitalization for Acute Decompensated Heart Failure: Results From the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF)

V. Hasselblad, R. Califf, C. O'connor, 2014, Circulation.

Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

C. Held, E. Lonn, H. White, 2017, Journal of the American Heart Association.

Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.

R. Califf, E. Topol, H. White, 1997, Journal of the American College of Cardiology.

Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial

Deepak L. Bhatt, H. White, G. Stone, 2013, Coronary artery disease.

Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

M. Pfisterer, P. Armstrong, C. Granger, 2010, European heart journal.

Lack of progress in cardiogenic shock: lessons from the GUSTO trials

R. Califf, E. Topol, M. Pfisterer, 2000 .

Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial.

R. Califf, E. Topol, A. Lincoff, 2000, Journal of the American College of Cardiology.

Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators.

R. Califf, C. Granger, G. Wagner, 1997, Journal of the American College of Cardiology.

Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.

C. O'connor, P. Armstrong, C. Granger, 2011, Contemporary clinical trials.

Insights From the ESCAPE Trial

V. Hasselblad, R. Califf, C. Yancy, 2008 .

Cardiorenal interactions: insights from the ESCAPE trial.

V. Hasselblad, R. Califf, C. Yancy, 2008, Journal of the American College of Cardiology.

A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes.

R. Califf, E. Topol, C. Granger, 2000, The American journal of cardiology.

Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.

P. Armstrong, C. Granger, R. Kim, 2010, American heart journal.

Elevation Myocardial Infarction Treated With Fibrinolysis Association of Mortality With Years of Education in Patients With ST-Segment

R. Califf, E. Topol, P. Armstrong, 2012 .

Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis.

R. Califf, E. Topol, P. Armstrong, 2011, Journal of the American College of Cardiology.

Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study.

R. Califf, E. Topol, D. Holmes, 1997, Circulation.

Benefits of direct angioplasty for women and men with acute myocardial infarction: results of the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes Angioplasty (GUSTO II-B) Angioplasty Substudy.

S. Ellis, J. Hochman, A. Stebbins, 2004, American heart journal.

Dichotomous Relationship Between Age and 30-Day Death or Rehospitalization in Heart Failure Patients Admitted With Acute Decompensated Heart Failure: Results From the ASCEND-HF Trial.

V. Hasselblad, C. O'connor, J. McMurray, 2016, Journal of cardiac failure.

Survival Outcomes 1 Year After Reperfusion Therapy With Either Alteplase or Reteplase for Acute Myocardial Infarction: Results From the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial

A. Skene, R. Califf, E. Topol, 2000, Circulation.

Response to Exercise Training and Outcomes in Patients with Heart Failure and Diabetes Mellitus: Insights from HF-ACTION

S. Keteyian, I. Piña, E. Leifer, 2016 .

Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial

P. Ponikowski, K. Anstrom, P. Armstrong, 2022, Circulation. Heart failure.

Value of Cardiovascular Magnetic Resonance Imaging–Derived Baseline Left Ventricular Ejection Fraction and Volumes for Precise Risk Stratification of Patients With Ischemic Cardiomyopathy: Insights From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial

J. Rouleau, G. Pohost, A. Stebbins, 2017, JAMA cardiology.

CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial.

I. Piña, M. Drazner, P. Jhund, 2019, JACC. Heart failure.

Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial

P. Armstrong, C. Granger, K. Mahaffey, 2012, Journal of Thrombosis and Thrombolysis.

Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone.

A. Skene, R. Califf, E. Topol, 2002, The American journal of cardiology.

Integrating ancillary studies in a large clinical trial: the design and rationale of the APEX library.

Manesh R. Patel, P. Armstrong, C. Granger, 2008, Contemporary clinical trials.

Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries.

R. Califf, E. Topol, P. Armstrong, 2002, American heart journal.

Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy.

R. Califf, E. Topol, S. Ellis, 2001, American heart journal.

Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial.

W. Weaver, E. Ohman, C. Gibson, 2007, American heart journal.

Lack of progress in cardiogenic shock: lessons from the GUSTO trials.

R. Califf, E. Topol, M. Pfisterer, 2000, European heart journal.

Recurrent ischemia after thrombolysis: importance of associated clinical findings. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-plasminogen activator] for Occluded Coronary Arteries.

R. Califf, E. Topol, P. Aylward, 1998, Journal of the American College of Cardiology.

Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial

R. Califf, P. Armstrong, A. Ross, 1997 .

Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.

R. Califf, E. Topol, C. Granger, 1997, Journal of the American College of Cardiology.

Use of Intraaortic Balloon Counterpulsation in Patients Presenting With Cardiogenic Shock: Observations From the GUSTO-I Study fn1fn1This study was funded by grants from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California; ICI Pharmaceuticals,

R. Califf, E. Topol, C. Granger, 1997 .

Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.

R. Califf, E. Topol, D. Holmes, 1996, The American journal of cardiology.

Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study.

Manesh R. Patel, P. Armstrong, W. Weaver, 2013, American heart journal.

Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.

P. Armstrong, C. Granger, A. Stebbins, 2012, American heart journal.

Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study.

E. Ohman, S. Hazen, M. Farkouh, 2007, European heart journal.

Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction

D. Atar, P. Ponikowski, B. Lewis, 2022, European journal of heart failure.

Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).

V. Hasselblad, R. Califf, C. O'connor, 2013, Journal of the American College of Cardiology.

Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial.

Manesh R. Patel, Neha J. Pagidipati, R. Holman, 2021, Atherosclerosis.

Beta-blocker and ACE-inhibitor Dosing as a Function of Body Surface Area: From the HF-ACTION trial.

W. Kraus, I. Piña, C. O'connor, 2020, American heart journal.

V. Hasselblad, R. Califf, C. O'connor, 2014, Circulation.

Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".

C. O'connor, P. Armstrong, C. Granger, 2011, American heart journal.

Association Between Delays in Mechanical Ventilation Initiation and Mortality in Patients With Refractory Cardiogenic Shock.

R. Lopes, J. Alexander, J. Hochman, 2020, JAMA cardiology.

Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: findings from the APEX-AMI trial.

K. Alexander, P. Armstrong, C. Granger, 2011, Archives of internal medicine.

Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.

V. Hasselblad, P. Armstrong, C. Granger, 2013, International journal of cardiology.

Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.

F. Van de Werf, J. Alexander, J. Hochman, 2007, JAMA.

Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.

R. Califf, E. Topol, C. Granger, 1997, Journal of the American College of Cardiology.

Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction—Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF‐ACTION) randomized controlled trial

W. Kraus, I. Piña, C. O'connor, 2018, American heart journal.

Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial.

R. Califf, D. Mark, E. Topol, 1996, Journal of the American College of Cardiology.

Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries.

K. Lee, R. Califf, E. Topol, 1998, Journal of the American College of Cardiology.

Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).

R. Califf, E. Topol, H. White, 2004, The American journal of cardiology.

Mortality Implications of Primary Percutaneous Coronary Intervention Treatment Delays: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction Trial

P. Armstrong, W. Weaver, C. Granger, 2011, Circulation. Cardiovascular quality and outcomes.

Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery.

F. Van de Werf, J. Alexander, J. Hochman, 2009, American heart journal.

Recurrent Ischemia After Thrombolysis: Importance of Associated Clinical Findings fn1fn1This study was supported by grants from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmace

R. Califf, E. Topol, P. Aylward, 1998 .

Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries.

R. Califf, E. Topol, P. Armstrong, 1999, The American journal of cardiology.

Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators.

R. Califf, E. Topol, A. Natale, 1998, Circulation.

Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.

R. Califf, E. Topol, E. Ohman, 1999, Journal of the American College of Cardiology.

Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial).

R. Califf, L. Newby, K. Mahaffey, 2007, American Journal of Cardiology.

Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial.

R. Califf, E. Topol, P. Armstrong, 2003, American heart journal.

Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathy

M. Drazner, D. Mark, H. White, 2018, Open Heart.

In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events.

P. Pais, C. Held, R. Diaz, 2020, American heart journal.

Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease

C. Held, E. Lonn, H. White, 2016, European heart journal.

Outcomes among patients with peripheral artery disease in the Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) study

Catherine P. Benziger, B. Hammill, Adrian F. Hernandez, 2023, Vascular medicine.

Sex Differences in Quality of Life and Clinical Outcomes in Patients With Advanced Heart Failure

Neha J. Pagidipati, C. O'connor, J. Tulsky, 2020, Circulation. Heart failure.

Predictors of early dyspnoea relief in acute heart failure and the association with 30‐day outcomes: findings from ASCEND‐HF

V. Hasselblad, D. Atar, P. Ponikowski, 2013, European journal of heart failure.

Abstract 18856: Relationships Between ‘Mediterranean’ and ‘Western’ Dietary Patterns and Major Cardiovascular Events in Patients With Stable Coronary Heart Disease in the STABILITY Study

C. Held, E. Lonn, H. White, 2014 .

Abstract 19384: Favorable Association Between a Mediterranean Dietary Pattern and Cardiovascular Risk Factors in Patients with Stable Coronary Heart Disease in the STABILITY Study

C. Held, E. Lonn, E. Hagström, 2014 .

Intravenous adenosine diphosphate P2T platelet receptor antagonism as an adjunct to fibrinolysis for acute myocardial infarction

E. Ohman, S. Borzak, A. Stebbins, 2002 .

Facilitated angioplasty with combined ADP P2T receptor blockade and fibrinolysis for the treatment of acute myocardial infarction: results from the STEP-AMI trial

J. A. Painter, W. Weaver, A. Stebbins, 2002 .

Tooth loss is independently associated with poor outcomes in stable coronary heart disease

C. Held, H. White, E. Hagström, 2016, European journal of preventive cardiology.

Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease

C. Held, P. Armstrong, H. White, 2019, Journal of the American Heart Association.

Comparison of the effectiveness and safety of two aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: a subgroup analysis of ADAPTABLE.

D. DeWalt, Adrian F. Hernandez, M. Effron, 2023, American Heart Journal.

Mode of Death in Contemporary Heart Failure Patients and the Impact of Structured Exercise: Insights from the HF-ACTION Trial

W. Kraus, C. O'connor, D. Bensimhon, 2013 .

Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease

C. Held, P. Armstrong, H. White, 2018, Journal of internal medicine.

Renal function and coronary bypass surgery in patients with ischemic heart failure.

J. Rouleau, A. Stebbins, G. Sopko, 2020, The Journal of thoracic and cardiovascular surgery.

Pooled analysis of adverse event collection from 4 acute coronary syndrome trials.

C. Held, K. Alexander, E. Ohman, 2016, American heart journal.

Patterns of Change in Individual Domains of the Kansas City Cardiomyopathy Questionnaire with a Palliative Care Intervention for Patients with Advanced Heart Failure: Insights from PAL-HF.

K. Anstrom, C. O'connor, J. Tulsky, 2021, Journal of cardiac failure.